Discussions about determining structure for health insurance benefits

A place was prepared to discuss about improvements in the determining structure for health insurance benefits, which attract sharp attention of the pharmaceutical industry, and to collect opinions from the field.

Director Byung-Il Lee at the Health Insurance Review & Assessment Service Drug Control Office emphasized “We’ll look for improvements on the pharmaceutical registration process after ...